Carfilzomib May Offer Advantages in Patients with Relapsed/Refractory Multiple Myeloma - The ASCO Post

Links shared publicly online about this topic.

  • 0
    total visits

Carfilzomib May Offer Advantages in Patients with Relapsed/Refractory Multiple Myeloma - The ASCO Post

ascopost.com —

Carfilzomib May Offer Advantages in Patients with Relapsed/Refractory Multiple Myeloma - The ASCO Post

View full resource at ascopost.com

Tags: Multiple Myeloma

  • Share

Most Recently Shared on March 14, 2012 at 3:50 pm By:

ASCOPost The ASCO Post

#Carfilzomib May Offer Advantages in Patients with Relapsed/Refractory #MultipleMyeloma http://t.co/hI6T0uSF

1 month ago...

Reply

Retweet

Favorite

Advertisement